When medication-related injury disrupts the body’s energy system, the effects can be widespread—and often misunderstood.
Millions of people live with unexplained pain, fatigue, neurological symptoms, tendon ruptures, autonomic instability, psychological changes, and progressive multi-system decline following medication exposure. Too often, they are told these symptoms are unrelated, idiopathic, or functional.
DIMD Is a Public Health Issue — Not a Rare Event
More than 400 medications carry FDA boxed warnings, nearly half of which involve mechanisms known to impair mitochondrial function. These drugs are widely prescribed—often repeatedly—without screening or long-term monitoring, and most critically, without patients being informed that the medications they are prescribed may cause irreparable mitochondrial DNA damage, potentially resulting in lifelong and irreversible harm.
This site exists because drug-induced mitochondrial dysfunction is not rare.
Evidence increasingly suggests it is far more common than currently recognized.
This platform is dedicated to:
- Patient education
- Clinician awareness
- Research infrastructure
- National registry development
- Legislative advocacy
We are building the missing bridge between drug exposure and delayed, multi-system disease.
*Despite decades of use, no national system currently tracks delayed, cumulative mitochondrial injury following drug exposure.
DIMD 